Compare Addus HomeCare Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
USD 1,882 Million (Small Cap)
19.00
NA
0.00%
0.06
9.35%
1.79
Revenue and Profits:
Net Sales:
373 Million
(Quarterly Results - Dec 2025)
Net Profit:
30 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.41%
0%
-11.41%
6 Months
-9.59%
0%
-9.59%
1 Year
9.09%
0%
9.09%
2 Years
-1.9%
0%
-1.9%
3 Years
1.37%
0%
1.37%
4 Years
22.04%
0%
22.04%
5 Years
-7.36%
0%
-7.36%
Addus HomeCare Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.16%
EBIT Growth (5y)
20.23%
EBIT to Interest (avg)
11.92
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
1.16
Tax Ratio
24.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.39%
ROE (avg)
9.00%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.79
EV to EBIT
14.26
EV to EBITDA
12.81
EV to Capital Employed
1.75
EV to Sales
1.44
PEG Ratio
0.64
Dividend Yield
NA
ROCE (Latest)
12.26%
ROE (Latest)
9.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 97 Schemes (49.92%)
Foreign Institutions
Held by 126 Foreign Institutions (6.97%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
373.10
297.10
25.58%
Operating Profit (PBDIT) excl Other Income
56.80
43.20
31.48%
Interest
2.70
2.30
17.39%
Exceptional Items
-10.40
-16.80
38.10%
Consolidate Net Profit
29.80
19.50
52.82%
Operating Profit Margin (Excl OI)
141.20%
134.50%
0.67%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 25.58% vs 7.49% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 52.82% vs -0.51% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,422.50
1,154.60
23.20%
Operating Profit (PBDIT) excl Other Income
165.40
129.30
27.92%
Interest
13.60
7.70
76.62%
Exceptional Items
-10.40
-16.80
38.10%
Consolidate Net Profit
95.90
73.60
30.30%
Operating Profit Margin (Excl OI)
104.80%
100.20%
0.46%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 23.20% vs 9.06% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 30.30% vs 17.76% in Dec 2024
About Addus HomeCare Corp. 
Addus HomeCare Corp.
Pharmaceuticals & Biotechnology
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company's personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living. The Company provides these non-medical services on a long-term, continuous basis. The Company delivers services to its consumers through 180 individual agencies located in 25 states. Its services, which include non-medical care, such as personal care services, are provided to consumers who are unable to independently perform some or all of their activities of daily living.
Company Coordinates 
Company Details
6303 COWBOYS WAY, SUITE 600 , FRISCO TX : 75034
Registrar Details






